Mar 17, 2024 | Antithrombotics
1b) @AnticoagPharmD is Systems Director of Anticoagulation Services and also is the Co-Chair of the @NATF Thrombosis Medical Advisory Board & the @AnticoagForum ACE committee. She will be discussing the very exciting #CodeICH project that launched with...
Feb 26, 2024 | Antithrombotics
2) The article is at 🔓https://t.co/pcn3xUfoWf and our content expert for this program is the 1⃣st author, Kevin Sheth MD @sheth_kevin, Professor of #Neurology & #Neurosurgery from @YaleMed & the Yale Center for Brain & Mind Health (CBMH) 🧠...
Feb 6, 2024 | Antithrombotics
2) Our returning expert author is #ANNEXa_I investigator Ashkan Shoamanesh MD @Ash_Shoamanesh, #Stroke #Neurologist @HamHealthSci, Assoc Prof @McMasterU, & Director of Hemorrhagic Stroke Research Program & Scientist @PHRIresearch #FOAMed #FOAMcc #neurotwitter...
Jan 7, 2024 | Antithrombotics
2a) The program is intended for #healthcare professionals & supported by an independent educational grant from Anthos Therapeutics. Statement of accreditation & faculty disclosures at https://t.co/gvXca4G9Xm.— cardio-met (@cardiomet_CE) January 9, 2024...
Dec 19, 2023 | Antithrombotics
2) This program is a #journalclub. The reviewed article is at https://t.co/TwtVzbcO82. It comes from the Golden Jubilee National Hospital, Clydebank, UK. 🏴🇬🇧 The authors are #NawwarAlAttara #AhmedSedeeka Philip McCall @philipmccall #JenniferTravers...
Dec 14, 2023 | Antithrombotics
2) That prior program shared and explained the results of the #LBCT data from #AZALEA_TIMI_71 at #AHA23. Lots has happened in the #FXI world since then, so it's time revisit and recap. pic.twitter.com/caxbJHB0ML— cardio-met (@cardiomet_CE) December 14, 2023...